Turn Therapeutics Inc. logo

Turn Therapeutics Inc. (TTRX)

Market Closed
11 Jun, 20:00
NASDAQ (NMS) NASDAQ (NMS)
$
5. 86
+0.33
+5.9675%
$
150.58M Market Cap
- P/E Ratio
- Div Yield
29,679 Volume
- Eps
$ 5.53
Previous Close
Investors:
Add Transaction
Day Range
5.38 6.01
Year Range
2.57 26.5
Want to track TTRX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

TTRX closed today higher at $5.86, an increase of 5.9675% from yesterday's close, completing a monthly decrease of -6.9841% or -$0.44. Over the past 12 months, TTRX stock gained 39.8568%.
TTRX is not paying dividends to its shareholders.
The last earnings report, released on Jun 03, 2026, exceeded the consensus estimates by 0.025%. On average, the company has surpassed earnings expectations by 0.0083%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on one exchange.

TTRX Chart

People also search for

Larimar Therapeutics Inc.
$ 3.6
+4.6512%
Zentalis Pharmaceuticals, Inc.
$ 3.52
-2.2222%
Entrada Therapeutics Inc.
$ 6.31
+5.6951%
ALT
Altimmune, Inc.
$ 2.59
-0.7663%
Fate Therapeutics Inc.
$ 1.97
+5.3476%

Turn Therapeutics Inc. Investors

Name Quantity Cost Value Profit ($) Gain (%)
YA
Yinka Akinsola Blue Trust Inc.
1,122 $4,420.68 $6,574.92 $2,154.24 48.73%

Turn Therapeutics Inc. (TTRX) FAQ

What is the stock price today?

The current price is $5.86.

On which exchange is it traded?

Turn Therapeutics Inc. is listed on NASDAQ (NMS).

What is its stock symbol?

The ticker symbol is TTRX.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 150.58M.

Has Turn Therapeutics Inc. ever had a stock split?

No, there has never been a stock split.

Turn Therapeutics Inc. Profile

Biotechnology Industry
Healthcare Sector
Bradley E. Burnam CEO
NASDAQ (NMS) Exchange
90021W105 CUSIP
US Country
2 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Global Health Solutions, Inc., operating under the name Turn Therapeutics, is a dynamic pharmaceuticals company dedicated to developing innovative treatments for various diseases affecting the skin, nails, and eyes. Incorporated in 2015 and headquartered in Westlake Village, California, the company specializes in leveraging advanced delivery technologies that allow for deeper penetration into the skin and nails. This approach not only enhances the efficacy of their products but also plays a crucial role in reducing antibiotic resistance, an increasingly prevalent issue in acute and chronic wound care environments. Turn Therapeutics aims to equip healthcare institutions with effective solutions that address a wide spectrum of skin conditions, from urgent acute wounds to longer-term chronic dermatoses.

Products and Services

  • Acute Wound Care Products

    These products are specifically designed to address urgent skin injuries, promoting faster healing and reducing the risk of infection through advanced formulations that penetrate deeply to deliver active ingredients effectively.

  • Chronic Wound Care Solutions

    Tailored for patients dealing with long-lasting and complex wounds, these solutions focus on providing sustained relief and support, integrating technology that mitigates antibiotic resistance while promoting natural healing processes.

  • Dermatological Conditions Treatments

    This range of products targets various skin conditions and dermatoses, utilizing innovative delivery mechanisms to ensure effective treatment of issues such as eczema, psoriasis, and other inflammatory skin disorders.

  • Nail Care Solutions

    Addressing problems specifically related to the nails, these products are formulated to treat fungal infections and other nail disorders, ensuring both health and aesthetic appeal by promoting robust nail growth and recovery.

  • Eye Care Treatments

    Focused on ocular health, these therapeutics aim to provide relief from eye-related conditions through advanced drug formulations that effectively target inflammation and infection while ensuring minimal side effects.

Contact Information

Address: 250 N Westlake Blvd
Phone: 818 546 4011